Login to Your Account

Other News To Note

Friday, September 28, 2012
• Discovery Laboratories Inc., of Warrington, Pa., began four research projects with its KL4 sufractant technology for acute lung injury. The preclinical studies will be in collaboration with research institutions, and funded through U.S. government-sponsored biodefense initiatives.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription